Skip to main content
Top
Published in: Annals of Surgical Oncology 6/2009

01-06-2009 | Gastrointestinal Oncology

Single-Nucleotide Polymorphisms of DNA Repair Genes OGG1 and XRCC1: Association with Gallbladder Cancer in North Indian Population

Authors: Anvesha Srivastava, MSc, Kshitij Srivastava, MSc, Sachchida Nand Pandey, PhD, G. Choudhuri, MD, B. Mittal, PhD

Published in: Annals of Surgical Oncology | Issue 6/2009

Login to get access

Abstract

Background

DNA damage by endogenous or exogenous source of reactive oxygen species (ROS) plays an important role in induction and progression of various cancers. Physiologically, gallbladder is likely to be exposed to various ROS which leads to extensive DNA damage. Cells overcome the DNA damage by repair mechanisms. Genetic variants of OGG1 and XRCC1, important enzymes participating in base excision repair pathway, may confer interindividual variations in susceptibility to gallbladder cancer (GBC). This study was aimed to examine the role of OGG1 Ser326Cys (rs1052133) and XRCC1 Arg194Trp (C > T) (rs25487) and Arg399Gln (G > A) (rs1799782) polymorphisms in GBC susceptibility.

Methods

The study included 173 GBC patients and 204 controls. Genotyping was done by polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP) method. Differences in the frequencies were estimated by chi-square test and risk was estimated by using unconditional logistic regression after adjusting for age and gender.

Results

OGG1Cys/Cys genotype frequency was significantly higher in GBC patients [odds ratio (OR) = 2.93; 95% confidence interval (CI) = 1.14–7.51]. The increased risk was more pronounced in female GBC patients (OR = 5.92; 95%CI = 1.20–29.13), patients with gallstone (OR = 5.50; 95%CI = 1.99–15.16), female gender, and late onset of disease (OR = 4.72, 95%CI = 1.43–15.53).
In XRCC1 Arg399Gln polymorphism, significant differences in frequencies of Gln/Gln and Arg/Gln genotypes conferred significantly low risk for GBC (OR = 0.62; 95%CI = 0.39–0.97 and OR = 0.37; 95%CI = 0.19–0.71 respectively).
However, XRCC1 Arg194Trp polymorphism was not associated with GBC. The carriers of Arg-Gln haplotype consisting of 194Arg and 399Gln alleles of XRCC1 were also at significant low risk for GBC (OR = 0.59, 95%CI = 0.42–0.82). Interaction of genotypes and tobacco usage did not modulate the risk.

Conclusion

Results suggest that Cys/Cys genotype of OGG1 Ser326Cys polymorphism is associated with increased risk of GBC. However, Arg399Gln polymorphism and Arg-Gln haplotype comprising XRCC1 Arg194Trp and Arg399Gln polymorphisms conferred low risk for GBC susceptibility.
Literature
1.
go back to reference Randi G, Franceschi S, La Vecchia C. Gallbladder cancer worldwide: Geographical distribution and risk factors. Int J Cancer. 2006;118:1591–1602.PubMedCrossRef Randi G, Franceschi S, La Vecchia C. Gallbladder cancer worldwide: Geographical distribution and risk factors. Int J Cancer. 2006;118:1591–1602.PubMedCrossRef
2.
go back to reference Coleman MP, Esteve J, Damiecki P, Arslan A, Renard H. Trends in cancer incidence and mortality, Lyon, IARC 1993. Coleman MP, Esteve J, Damiecki P, Arslan A, Renard H. Trends in cancer incidence and mortality, Lyon, IARC 1993.
3.
go back to reference Wistuba II, Gazdar AF. Gallbladder cancer: lessons from a rare tumor. Nat Rev Cancer. 2004;4:695–706.PubMedCrossRef Wistuba II, Gazdar AF. Gallbladder cancer: lessons from a rare tumor. Nat Rev Cancer. 2004;4:695–706.PubMedCrossRef
4.
go back to reference Lazcano-Ponce EC, Miquel JF, Munoz N. Epidemiology and molecular pathology of gallbladder cancer. CA Cancer J Clin. 2001;51:349–64.PubMedCrossRef Lazcano-Ponce EC, Miquel JF, Munoz N. Epidemiology and molecular pathology of gallbladder cancer. CA Cancer J Clin. 2001;51:349–64.PubMedCrossRef
5.
go back to reference Takahashi T, Shivapurkar N, Riquelme E. Aberrant promoter hypermethylation of multiple genes in gallbladder carcinoma and chronic cholecystitis. Clin Cancer Res. 2004;10:6126–33.PubMedCrossRef Takahashi T, Shivapurkar N, Riquelme E. Aberrant promoter hypermethylation of multiple genes in gallbladder carcinoma and chronic cholecystitis. Clin Cancer Res. 2004;10:6126–33.PubMedCrossRef
6.
go back to reference Chatterjee A, Mambo E, Zhang Y, De Weese T, Sidransky D. Targeting of mutant hogg1 in mammalian mitochondria and nucleus: effect on cellular survival upon oxidative stress. BMC Cancer. 2006;6:235.PubMedCrossRef Chatterjee A, Mambo E, Zhang Y, De Weese T, Sidransky D. Targeting of mutant hogg1 in mammalian mitochondria and nucleus: effect on cellular survival upon oxidative stress. BMC Cancer. 2006;6:235.PubMedCrossRef
7.
go back to reference Sakamoto T, Higaki Y, Hara M, Ichiba M, Horita M, Mizuta T, et al. Ser326Cys Polymorphism and risk of hepatocellular carcinoma among Japanese. J Epidemiol. 2006;16:233–9.PubMedCrossRef Sakamoto T, Higaki Y, Hara M, Ichiba M, Horita M, Mizuta T, et al. Ser326Cys Polymorphism and risk of hepatocellular carcinoma among Japanese. J Epidemiol. 2006;16:233–9.PubMedCrossRef
8.
go back to reference Elahi A, Zheng Z, Park J, Eyring K, McCaffrey T, Lazarus P. The human OGG1 DNA repair enzyme and its association with orolaryngeal cancer risk. Carcinogenesis. 2002;23:1229–34.PubMedCrossRef Elahi A, Zheng Z, Park J, Eyring K, McCaffrey T, Lazarus P. The human OGG1 DNA repair enzyme and its association with orolaryngeal cancer risk. Carcinogenesis. 2002;23:1229–34.PubMedCrossRef
9.
go back to reference Speina E, Arczewska KD, Gackowski D, Zieli ń ska M, Siomek A, Kowalewski J, et al. Contribution of hMTH1 to the maintenance of 8-oxoguanine levels in lung DNA of non-small-cell lung cancer patients. J Natl Cancer Inst. 2005;97:384–95.PubMedCrossRef Speina E, Arczewska KD, Gackowski D, Zieli ń ska M, Siomek A, Kowalewski J, et al. Contribution of hMTH1 to the maintenance of 8-oxoguanine levels in lung DNA of non-small-cell lung cancer patients. J Natl Cancer Inst. 2005;97:384–95.PubMedCrossRef
10.
go back to reference Bravard A, Vacher M, Gouget B, Coutant A, Hillairet de Boisferon F, Marsin S, et al. Redox regulation of human OGG1 activity in response to cellular oxidative stress. Mol Cell Biol. 2006;26:7430–6.PubMedCrossRef Bravard A, Vacher M, Gouget B, Coutant A, Hillairet de Boisferon F, Marsin S, et al. Redox regulation of human OGG1 activity in response to cellular oxidative stress. Mol Cell Biol. 2006;26:7430–6.PubMedCrossRef
11.
go back to reference Nyaga SG, Lohani A, Jaruga P, Trzeciak AR, Dizdaroglu M, Evans MK. Reduced repair of 8-hydroxyguanine in the human breast cancer cell line, HCC1937. BMC Cancer. 2006;6:297.PubMedCrossRef Nyaga SG, Lohani A, Jaruga P, Trzeciak AR, Dizdaroglu M, Evans MK. Reduced repair of 8-hydroxyguanine in the human breast cancer cell line, HCC1937. BMC Cancer. 2006;6:297.PubMedCrossRef
12.
go back to reference Ide H, Kotera M. Human DNA Glycosylases involved in the repair of oxidatively damaged DNA. Biol Pharm Bull. 2004;27:480–5.PubMedCrossRef Ide H, Kotera M. Human DNA Glycosylases involved in the repair of oxidatively damaged DNA. Biol Pharm Bull. 2004;27:480–5.PubMedCrossRef
13.
go back to reference Zhang H, Mizumachi T, Carcel-Trullols J, Li L, Naito A, Spencer HJ, et al. Targeting human 8-oxoguanine DNA glycosylase (hOGG1) to mitochondria enhances cisplatin cytotoxicity in hepatoma cells. Carcinogenesis. 2007;28:1629–37.PubMedCrossRef Zhang H, Mizumachi T, Carcel-Trullols J, Li L, Naito A, Spencer HJ, et al. Targeting human 8-oxoguanine DNA glycosylase (hOGG1) to mitochondria enhances cisplatin cytotoxicity in hepatoma cells. Carcinogenesis. 2007;28:1629–37.PubMedCrossRef
14.
go back to reference Park HW, Kim IJ, Kang HC, Jang SG, Ahn SA, Lee JS, et al. The hOGG1 Ser326Cys polymorphism is not associated with colorectal cancer. Risk J Epidemiol. 2007;17:156–60.CrossRef Park HW, Kim IJ, Kang HC, Jang SG, Ahn SA, Lee JS, et al. The hOGG1 Ser326Cys polymorphism is not associated with colorectal cancer. Risk J Epidemiol. 2007;17:156–60.CrossRef
15.
go back to reference Jiao X, Huang J, Wu S, Lv M, Hu Y, Jianfu, et al. hOGG1 Ser326Cys polymorphism and susceptibility to gallbladder cancer in a Chinese population. Int J Cancer. 2007;121:501–5.PubMedCrossRef Jiao X, Huang J, Wu S, Lv M, Hu Y, Jianfu, et al. hOGG1 Ser326Cys polymorphism and susceptibility to gallbladder cancer in a Chinese population. Int J Cancer. 2007;121:501–5.PubMedCrossRef
16.
go back to reference Han J, Hankinson SE, De Vivo I, Spiegelman D, Tamimi RM, Mohrenweiser HW, et al. A prospective study of XRCC1 haplotypes and their interaction with plasma carotenoids on breast cancer risk. Cancer Res. 2003;63:8536–41.PubMed Han J, Hankinson SE, De Vivo I, Spiegelman D, Tamimi RM, Mohrenweiser HW, et al. A prospective study of XRCC1 haplotypes and their interaction with plasma carotenoids on breast cancer risk. Cancer Res. 2003;63:8536–41.PubMed
17.
go back to reference Chang-Claude J, Popanda O, Tan XL, Kropp S, Helmbold I, von Fournier D, et al. Associations between polymorphisms in the DNA repair genes, XRCC1, APE1, and XPD and acute side effects of radiotherapy in breast cancer patients. Clin Cancer Res. 2005;11:4802–9.PubMedCrossRef Chang-Claude J, Popanda O, Tan XL, Kropp S, Helmbold I, von Fournier D, et al. Associations between polymorphisms in the DNA repair genes, XRCC1, APE1, and XPD and acute side effects of radiotherapy in breast cancer patients. Clin Cancer Res. 2005;11:4802–9.PubMedCrossRef
18.
go back to reference Jennifer JH, Tasha RS, Mark SM, Harvey WM, Andrea G, Douglas Case L. Amino acid substitution variants of APE1 and XRCC1 genes associated with ionizing radiation sensitivity. Carcinogenesis. 2001;22:917–22.CrossRef Jennifer JH, Tasha RS, Mark SM, Harvey WM, Andrea G, Douglas Case L. Amino acid substitution variants of APE1 and XRCC1 genes associated with ionizing radiation sensitivity. Carcinogenesis. 2001;22:917–22.CrossRef
19.
go back to reference Bearhs O, Henson D, Hutter R (1988) Manual for staging of cancer. Philadelphia: Lippincott; 1988. Bearhs O, Henson D, Hutter R (1988) Manual for staging of cancer. Philadelphia: Lippincott; 1988.
20.
go back to reference Miller SA, Dykes DD, Polesky HF. A salting procedure for extracting DNA from nucleated cells. Nucl Acid Res. 1988;16:1215.CrossRef Miller SA, Dykes DD, Polesky HF. A salting procedure for extracting DNA from nucleated cells. Nucl Acid Res. 1988;16:1215.CrossRef
21.
go back to reference Ramachandran S, Ramadas K, Hariharan R, Kumar RR, Pillai MR. Single nucleotide polymorphisms of DNA repair genes XRCC1 and XPD and its molecular mapping in Indian oral cancer. Oral Oncol. 2006;42:350–62.PubMedCrossRef Ramachandran S, Ramadas K, Hariharan R, Kumar RR, Pillai MR. Single nucleotide polymorphisms of DNA repair genes XRCC1 and XPD and its molecular mapping in Indian oral cancer. Oral Oncol. 2006;42:350–62.PubMedCrossRef
22.
go back to reference Loïc Le M, Timothy D, Annette LJ, Ann S, Lynne R. Association of the hOGG1 Ser326Cys polymorphism with lung cancer risk. Cancer Epidemiol Biomarkers Prev. 2002;11:409–12. Loïc Le M, Timothy D, Annette LJ, Ann S, Lynne R. Association of the hOGG1 Ser326Cys polymorphism with lung cancer risk. Cancer Epidemiol Biomarkers Prev. 2002;11:409–12.
23.
go back to reference Kohno T, Kunitoh H, Toyama K, Yamamoto S, Kuchiba A, Saito D, et al. Association of the OGG1-Ser326Cys polymorphism with lung adenocarcinoma risk. Cancer Sci. 2006;97:724–8.PubMedCrossRef Kohno T, Kunitoh H, Toyama K, Yamamoto S, Kuchiba A, Saito D, et al. Association of the OGG1-Ser326Cys polymorphism with lung adenocarcinoma risk. Cancer Sci. 2006;97:724–8.PubMedCrossRef
24.
go back to reference Shen J, Deininger P, Hunt JD, Zhao H. 8-Hydroxy–20-deoxyguanosine (8-OH-dG) as a potential survival biomarker in patients with nonsmall-cell lung cancer. Cancer. 2007;109:574–80.PubMedCrossRef Shen J, Deininger P, Hunt JD, Zhao H. 8-Hydroxy–20-deoxyguanosine (8-OH-dG) as a potential survival biomarker in patients with nonsmall-cell lung cancer. Cancer. 2007;109:574–80.PubMedCrossRef
25.
go back to reference Luna L, Rolseth V, Hildrestrand GA, Otterlei M, Dantzer F, Bjørås M, et al. Dynamic relocalization of hOGG1 during the cell cycle is disrupted in cells harboring the hOGG1-Cys326 polymorphic variant. Nucl Acids Res. 2005;33:1813–24.PubMedCrossRef Luna L, Rolseth V, Hildrestrand GA, Otterlei M, Dantzer F, Bjørås M, et al. Dynamic relocalization of hOGG1 during the cell cycle is disrupted in cells harboring the hOGG1-Cys326 polymorphic variant. Nucl Acids Res. 2005;33:1813–24.PubMedCrossRef
26.
go back to reference Sugimura H, Kohno T, Wakai K. hOGG1 Ser326Cys polymorphism and lung cancer susceptibility. Cancer Epidemiol Biomarkers Prev. 1999;8:669–74.PubMed Sugimura H, Kohno T, Wakai K. hOGG1 Ser326Cys polymorphism and lung cancer susceptibility. Cancer Epidemiol Biomarkers Prev. 1999;8:669–74.PubMed
27.
go back to reference Marchand L Le, Donlon T, Lum-Jones A, Seifried A, Wilkens LR. Association of the hOGG1 Ser326Cys polymorphism with lung cancer risk. Cancer Epidemiol Biomarkers Prev. 2002;11:409–12.PubMed Marchand L Le, Donlon T, Lum-Jones A, Seifried A, Wilkens LR. Association of the hOGG1 Ser326Cys polymorphism with lung cancer risk. Cancer Epidemiol Biomarkers Prev. 2002;11:409–12.PubMed
28.
go back to reference Xing DY, Tan W, Song N, Lin DX. Ser326Cys polymorphism in hOGG1 gene and risk of esophageal cancer in a Chinese population. Int J Cancer. 2001;95:140–3.PubMedCrossRef Xing DY, Tan W, Song N, Lin DX. Ser326Cys polymorphism in hOGG1 gene and risk of esophageal cancer in a Chinese population. Int J Cancer. 2001;95:140–3.PubMedCrossRef
29.
go back to reference Sheehan AM, McGregor DK, Patel A, Shidham V, Fan CY, Chang CC. Expression of human 8-oxoguanine DNA glycosylase (hOGG1) in follicular lymphoma. Mod Pathol. 2006;18:1512–8.CrossRef Sheehan AM, McGregor DK, Patel A, Shidham V, Fan CY, Chang CC. Expression of human 8-oxoguanine DNA glycosylase (hOGG1) in follicular lymphoma. Mod Pathol. 2006;18:1512–8.CrossRef
30.
go back to reference Shen M, Hung RJ, Brennan P, Malaveille C, Donato F, Placidi D, et al. Polymorphisms of the DNA repair genes XRCC1, XRCC3, XPD, interaction with environmental exposures, and bladder cancer risk in a case-control study in northern Italy. Cancer Epidemiol Biomark Prev. 2003;12:1234–40. Shen M, Hung RJ, Brennan P, Malaveille C, Donato F, Placidi D, et al. Polymorphisms of the DNA repair genes XRCC1, XRCC3, XPD, interaction with environmental exposures, and bladder cancer risk in a case-control study in northern Italy. Cancer Epidemiol Biomark Prev. 2003;12:1234–40.
31.
go back to reference Duell EJ, Wiencke JW, Cheng TJ, Varkonyi A, Zuo ZF, Ashok TDS. Polymorphisms in the DNA repair genes XRCC1and ERCC2 and biomarkers of DNA damage in human blood mononuclear cells. Carcinogenesis. 2000;21:965–71.PubMedCrossRef Duell EJ, Wiencke JW, Cheng TJ, Varkonyi A, Zuo ZF, Ashok TDS. Polymorphisms in the DNA repair genes XRCC1and ERCC2 and biomarkers of DNA damage in human blood mononuclear cells. Carcinogenesis. 2000;21:965–71.PubMedCrossRef
32.
go back to reference Hu JJ, Smith TR, Miller MS, Mohrenweiser HW, Golden A, Case LD. Amino acid substitution variants of APE1 and XRCC1 genes associated with ionizing radiation sensitivity. Carcinogenesis. 2001;22:917–22.PubMedCrossRef Hu JJ, Smith TR, Miller MS, Mohrenweiser HW, Golden A, Case LD. Amino acid substitution variants of APE1 and XRCC1 genes associated with ionizing radiation sensitivity. Carcinogenesis. 2001;22:917–22.PubMedCrossRef
33.
go back to reference Goode EL, Ulrich CM, Potter JD. Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomark Prev. 2002;11:1513–30. Goode EL, Ulrich CM, Potter JD. Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomark Prev. 2002;11:1513–30.
34.
go back to reference Huang WY, Gao YT, Rashid A, Sakoda LC, Deng J, Shen MC, et al. Selected base excision repair gene polymorphisms and susceptibility to biliary tract cancer and biliary stones: a population-based case-control study in China. Carcinogenesis. 2008;29:100–5.PubMedCrossRef Huang WY, Gao YT, Rashid A, Sakoda LC, Deng J, Shen MC, et al. Selected base excision repair gene polymorphisms and susceptibility to biliary tract cancer and biliary stones: a population-based case-control study in China. Carcinogenesis. 2008;29:100–5.PubMedCrossRef
35.
go back to reference Park JY, Lee SY, Jeon HS, Bae NC, Chae SC, Joo S, et al. Polymorphism of the DNA repair gene XRCC1 and risk of primary lung cancer. Cancer Epidemiol Biomark Prev. 2002;11:23–7. Park JY, Lee SY, Jeon HS, Bae NC, Chae SC, Joo S, et al. Polymorphism of the DNA repair gene XRCC1 and risk of primary lung cancer. Cancer Epidemiol Biomark Prev. 2002;11:23–7.
36.
go back to reference Zhou W, Liu G, Miller DP, Thurston SW, Xu LL, Wain JC, et al. Polymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking, and lung cancer risk. Cancer Epidemiol Biomark Prev. 2003;12:359–65. Zhou W, Liu G, Miller DP, Thurston SW, Xu LL, Wain JC, et al. Polymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking, and lung cancer risk. Cancer Epidemiol Biomark Prev. 2003;12:359–65.
37.
go back to reference Sturgis EM, Castillo EJ, Li L, Zheng R, Eicher SA, Clayman GL, et al. Polymorphisms of DNA repair gene XRCC1 in squamous cell carcinoma of the head and neck. Carcinogenesis. 1999;20:2125–9.PubMedCrossRef Sturgis EM, Castillo EJ, Li L, Zheng R, Eicher SA, Clayman GL, et al. Polymorphisms of DNA repair gene XRCC1 in squamous cell carcinoma of the head and neck. Carcinogenesis. 1999;20:2125–9.PubMedCrossRef
38.
go back to reference Shu XO, Cai Q, Gao YT, Wen W, Jin F, Zheng W. A Population-based case-control study of the Arg399Gln polymorphism in DNA repair gene XRCC1 and risk of breast cancer. Cancer Epidemiol Biomark Prev. 2003;12:1462–7. Shu XO, Cai Q, Gao YT, Wen W, Jin F, Zheng W. A Population-based case-control study of the Arg399Gln polymorphism in DNA repair gene XRCC1 and risk of breast cancer. Cancer Epidemiol Biomark Prev. 2003;12:1462–7.
39.
go back to reference Stern MC, Umbachvan DM, Gils CH, Lunn RM, Taylor JA. DNA repair gene XRCC1 polymorphisms, smoking, and bladder cancer risk. Cancer Epidemiol. Biomark Prev. 2001;10:125–31. Stern MC, Umbachvan DM, Gils CH, Lunn RM, Taylor JA. DNA repair gene XRCC1 polymorphisms, smoking, and bladder cancer risk. Cancer Epidemiol. Biomark Prev. 2001;10:125–31.
40.
go back to reference Nelson HH, Kelsey KT, Mott LA, Karagas MR. The XRCC1 Arg399Gln polymorphism, sunburn, and non-melanoma skin cancer: evidence of gene–environment interaction. Cancer Res. 2002;62:152–5.PubMed Nelson HH, Kelsey KT, Mott LA, Karagas MR. The XRCC1 Arg399Gln polymorphism, sunburn, and non-melanoma skin cancer: evidence of gene–environment interaction. Cancer Res. 2002;62:152–5.PubMed
41.
go back to reference Misra RR, Ratnasinghe D, Tangrea JA, Virtamo J, Andersen MR, Barrett M, et al. Polymorphisms in the DNA repair genes XPD, XRCC1, XRCC3, and APE/ref–1, and the risk of lung cancer among male smokers in Finland. Cancer Lett. 2003;191:171–8.PubMedCrossRef Misra RR, Ratnasinghe D, Tangrea JA, Virtamo J, Andersen MR, Barrett M, et al. Polymorphisms in the DNA repair genes XPD, XRCC1, XRCC3, and APE/ref–1, and the risk of lung cancer among male smokers in Finland. Cancer Lett. 2003;191:171–8.PubMedCrossRef
42.
go back to reference Matullo G, Guarrera S, Carturan S, Peluso M, Malaveille C, Davico L, et al. DNA repair gene polymorphisms, bulky DNA adducts in white blood cells and bladder cancer in a case-control study. Int J Cancer. 2001;92:562–7.PubMedCrossRef Matullo G, Guarrera S, Carturan S, Peluso M, Malaveille C, Davico L, et al. DNA repair gene polymorphisms, bulky DNA adducts in white blood cells and bladder cancer in a case-control study. Int J Cancer. 2001;92:562–7.PubMedCrossRef
Metadata
Title
Single-Nucleotide Polymorphisms of DNA Repair Genes OGG1 and XRCC1: Association with Gallbladder Cancer in North Indian Population
Authors
Anvesha Srivastava, MSc
Kshitij Srivastava, MSc
Sachchida Nand Pandey, PhD
G. Choudhuri, MD
B. Mittal, PhD
Publication date
01-06-2009
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 6/2009
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-009-0354-3

Other articles of this Issue 6/2009

Annals of Surgical Oncology 6/2009 Go to the issue